Awiqli

Insulin icodec-abae · Novo Nordisk Pharmaceutical Industries, LP
PRESCRIPTION ONLY (USA)

Awiqli ingredients

Active ingredientStrength
Insulin Icodec700 U/mL

What Awiqli is used for

Awiqli is a specialist medicine. Its approved uses are listed on the official FDA label below.

Key facts

Brand
Awiqli
Generic name
Insulin icodec-abae
Made by
Novo Nordisk Pharmaceutical Industries, LP
Forms
Injection, Solution
Given
Subcutaneous
FDA approval
Biologic licence (BLA) BLA761326
On the US market since
2026

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Awiqli?

Awiqli (Insulin icodec-abae) is a specialist medicine made by Novo Nordisk Pharmaceutical Industries, LP, approved by the US FDA.

What are the ingredients of Awiqli?

Awiqli contains Insulin Icodec (700 U/mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.